Pure Global AI
NCT06375382Completed

Effects of Acupuncture on Abdominal Pain-related Intestinal Flora in Patients With Crohn's Disease

Shanghai Institute of Acupuncture, Moxibustion and MeridianClinicalTrials.govother
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
acupuncture
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2015
End date
Mar 31, 2024
Enrollment
64 participants
Primary outcome

Abdominal pain remission rate

Summary

Crohn's disease is an intestinal inflammatory disease, causing abdominal pain, diarrhea and
 other symptoms. The intestinal flora disorder is closely related to the occurrence and
 development of Crohn's disease. Acupuncture can induce remission of Crohn's disease during
 mild to moderate active period, improve clinical symptoms such as abdominal pain. This study
 is to screen the intestinal bacteria related to abdominal pain in CD, and explore the effects
 of acupuncture on the intestinal flora related to abdominal pain in CD patients.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06375382
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06375382 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian and is currently Completed. The study focuses on Crohn Disease. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.